EPIQ Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587K Hold
6,400
0.25% 56
2026
Q1
$545K Hold
6,400
0.25% 53
2025
Q4
$506K Hold
6,400
0.24% 52
2025
Q3
$512K Hold
6,400
0.24% 52
2025
Q2
$582K Hold
6,400
0.3% 49
2025
Q1
$600K Hold
6,400
0.32% 51
2024
Q4
$582K Hold
6,400
0.31% 50
2024
Q3
$664K Hold
6,400
0.37% 48
2024
Q2
$621K Hold
6,400
0.42% 44
2024
Q1
$576K Hold
6,400
0.38% 47
2023
Q4
$510K Hold
6,400
0.37% 44
2023
Q3
$455K Hold
6,400
0.34% 48
2023
Q2
$493K Hold
6,400
0.33% 49
2023
Q1
$481K Hold
6,400
0.33% 48
2022
Q4
$504K Hold
6,400
0.34% 51
2022
Q3
$450K Hold
6,400
0.28% 56
2022
Q2
$513K Hold
6,400
0.31% 57
2022
Q1
$485K Hold
6,400
0.26% 60
2021
Q4
$546K Hold
6,400
0.29% 56
2021
Q3
$484K Hold
6,400
0.22% 66
2021
Q2
$521K Hold
6,400
0.26% 57
2021
Q1
$505K Hold
6,400
0.29% 54
2020
Q4
$547K Hold
6,400
0.38% 47
2020
Q3
$513K Hold
6,400
0.39% 47
2020
Q2
$469K Hold
6,400
0.43% 45
2020
Q1
$425K Hold
6,400
0.47% 48
2019
Q4
$441K Buy
+6,400
New +$436K 0.45% 50

Other funds holding CL

EPIQ Partners's CL Position: Q2 2026 in Review

EPIQ Partners held its Colgate-Palmolive (CL) position steady in Q2 2026 at 6,400 shares worth $587K. The position accounts for 0.25% of the portfolio, ranked #56.

EPIQ Partners first reported a position in CL in Q4 2019 and has held it in 27 quarters since. The position peaked at $664K in Q3 2024. 396 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • EPIQ Partners held 6,400 shares of Colgate-Palmolive worth $587K as of Q2 2026.
  • EPIQ Partners left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.25% of EPIQ Partners's portfolio in Q2 2026, its #56 holding.
  • EPIQ Partners first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 27 quarters since.
  • EPIQ Partners's Colgate-Palmolive position peaked at $664K in Q3 2024.
  • 396 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on EPIQ Partners's 13F filing for Q2 2026, filed 7 Jul 2026.